Your browser doesn't support javascript.
loading
A recombinant affitoxin derived from a HER3 affibody and diphteria-toxin has potent and selective antitumor activity.
Nazari, Mahboobeh; Emamzadeh, Rahman; Jahanpanah, Maryam; Yazdani, Elnaz; Radmanesh, Ramin.
Affiliation
  • Nazari M; Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran. Electronic address: ma.nazari@avicenna.ac.ir.
  • Emamzadeh R; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
  • Jahanpanah M; Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
  • Yazdani E; Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
  • Radmanesh R; Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Int J Biol Macromol ; 219: 1122-1134, 2022 Oct 31.
Article in En | MEDLINE | ID: mdl-36041577
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Diphtheria Toxin Limits: Female / Humans Language: En Journal: Int J Biol Macromol Year: 2022 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Diphtheria Toxin Limits: Female / Humans Language: En Journal: Int J Biol Macromol Year: 2022 Document type: Article Country of publication: Netherlands